GlassScriptPhysician profile
John W Zinsser
NPI 1700813334
$1,823.58
in general payments reported to CMS, 2019-2025
11 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $315 · 2021: $84.48 · 2022: $381 · 2023: $77.96 · 2024: $413 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $594.21 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $426.02 | 2019-2024 | |
| Sientra, INC. | $339.43 | 2020-2022 | |
| Galderma Laboratories, L.P. | $302.53 | 2019-2025 | Dysport |
| Abbvie INC. | $41.88 | 2024 | |
| Davol INC. | $31.30 | 2025 | Arista |
| Innovation Technologies INC | $20.36 | 2020 | |
| Integra Lifesciences Corporation | $20.03 | 2023 | Durasorb Monofilament Mesh |
| Coopersurgical, INC. | $16.62 | 2025 | Insorb |
| Sanara Medtech INC. | $16.30 | 2025 | Biasurge |
| Allergan, INC. | $14.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Zinsser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.